Mark W. Kroll
Director at Haemonetics; Director at Axon Enterprise. Based in Boston, Massachusetts.
- Rank
- 11772nd of 14,644
- Companies held
- 2
- Largest holding
- AXON, 51.0% of total
- Latest SEC filing
- Jul 24, 2026
What the $6.7M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Axon Enterprise AXON Common Stock | Directly | 11,135 | $306.98 | $3.4M | 51.0% | Form 4, May 12, 2023 |
| Haemonetics HAE Common Stock | Directly | 27,295 | $120.28 | $3.3M | 49.0% | Form 4, Jul 24, 2026 |
Share counts are the amounts Mark W. Kroll reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 11769 | Matt Abernethy Chief Financial Officer, Neurocrine Biosciences. San Diego, CA | $6.7M |
| 11770 | Ann M. Addison Corp VP & Chief HR Officer, Northrop Grumman. Falls Church, VA | $6.7M |
| 11771 | Travis Marquette President and COO, Burlington Stores. Burlington, NJ | $6.7M |
| 11772 | Mark W. Kroll Director, Haemonetics. Boston, MA | $6.7M |
| 11773 | Lei Zhang Schlitz Executive Vice President, Illinois Tool Works. Milwaukee, WI | $6.7M |
| 11774 | Esta E. Stecher Director, Jackson Financial. Lansing, MI | $6.7M |
| 11775 | Michael Thomas Henderson Director, Spyre Therapeutics. Waltham, MA | $6.7M |
Other Haemonetics insiders
All HAE insiders- Christopher Simon$53.5MPresident & CEO. #2395 overall
- Michelle L. Basil$8.3MEVP and General Counsel. #10132 overall
- James DArecca$6.5MEVP, Chief Financial Officer. #11365 overall
- Laurie A. Miller$4.9MSVP, Human Resources. #14523 overall
- Robert E. Abernathy$3.3MDirector. #14119 overall
- Charles Dockendorff$3.0MDirector. #4953 overall
Questions
How much stock does Mark W. Kroll own?
Mark W. Kroll holds $6,701,265 in listed stock based on SEC filings and current prices, mostly Axon Enterprise (AXON). That ranks 11772nd on the Stock Rich List.
Is this Mark W. Kroll's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Mark W. Kroll last buy or sell stock?
The most recent open-market trade on file is a purchase of 1,400 HAE shares on Nov 10, 2025 at $70.56.